Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure

Takashi Ishida, Satoshi Tanaka, Akiyuki Sakamoto, Takanobu Hirabayashi, Mikito Kawamata Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan Abstract: We report a successful ultrasound-guided transversus abdominis plane (TAP) block as an ana...

Full description

Bibliographic Details
Main Authors: Ishida T, Tanaka S, Sakamoto A, Hirabayashi T, Kawamata M
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Local and Regional Anesthesia
Subjects:
Online Access:https://www.dovepress.com/plasma-ropivacaine-concentration-after-tap-block-in-a-patient-with-car-peer-reviewed-article-LRA
_version_ 1818034739385204736
author Ishida T
Tanaka S
Sakamoto A
Hirabayashi T
Kawamata M
author_facet Ishida T
Tanaka S
Sakamoto A
Hirabayashi T
Kawamata M
author_sort Ishida T
collection DOAJ
description Takashi Ishida, Satoshi Tanaka, Akiyuki Sakamoto, Takanobu Hirabayashi, Mikito Kawamata Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan Abstract: We report a successful ultrasound-guided transversus abdominis plane (TAP) block as an analgesic option for minor abdominal surgery in a 66-year-old patient with cardiac, respiratory, and renal dysfunction caused by primary systemic amyloidosis. Bilateral TAP blocks with 120 mg (1.8 mg/kg) of ropivacaine provided sufficient intra- and postoperative analgesia for insertion of a continuous ambulatory peritoneal dialysis catheter. However, the plasma concentration of ropivacaine reached a maximum of 2.5 µg/mL at 15 minutes after the TAP block, a concentration that was potentially neurotoxic. Although apparent signs of local anesthetic systemic toxicity (LAST) such as convulsion or changes in an electrocardiogram were not observed, the patient became drowsy after the TAP block, which might be one of the mild symptoms of LAST. A TAP block by itself can thus be an anesthetic option for patients undergoing minor abdominal surgery. However, cardiac and renal dysfunction might influence the pharmacokinetics of a local anesthetic used, and attention should be paid to the possibility of LAST even with a low dose of a local anesthetic for patients with cardiac and renal failure. Keywords: transversus abdominis plane block, plasma concentration of ropivacaine, cardiac failure, renal dysfunction, central nervous toxicity
first_indexed 2024-12-10T06:43:57Z
format Article
id doaj.art-850ff7c9c6ab4a7ba966c6baa0cfa716
institution Directory Open Access Journal
issn 1178-7112
language English
last_indexed 2024-12-10T06:43:57Z
publishDate 2018-09-01
publisher Dove Medical Press
record_format Article
series Local and Regional Anesthesia
spelling doaj.art-850ff7c9c6ab4a7ba966c6baa0cfa7162022-12-22T01:58:43ZengDove Medical PressLocal and Regional Anesthesia1178-71122018-09-01Volume 11576040791Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failureIshida TTanaka SSakamoto AHirabayashi TKawamata MTakashi Ishida, Satoshi Tanaka, Akiyuki Sakamoto, Takanobu Hirabayashi, Mikito Kawamata Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan Abstract: We report a successful ultrasound-guided transversus abdominis plane (TAP) block as an analgesic option for minor abdominal surgery in a 66-year-old patient with cardiac, respiratory, and renal dysfunction caused by primary systemic amyloidosis. Bilateral TAP blocks with 120 mg (1.8 mg/kg) of ropivacaine provided sufficient intra- and postoperative analgesia for insertion of a continuous ambulatory peritoneal dialysis catheter. However, the plasma concentration of ropivacaine reached a maximum of 2.5 µg/mL at 15 minutes after the TAP block, a concentration that was potentially neurotoxic. Although apparent signs of local anesthetic systemic toxicity (LAST) such as convulsion or changes in an electrocardiogram were not observed, the patient became drowsy after the TAP block, which might be one of the mild symptoms of LAST. A TAP block by itself can thus be an anesthetic option for patients undergoing minor abdominal surgery. However, cardiac and renal dysfunction might influence the pharmacokinetics of a local anesthetic used, and attention should be paid to the possibility of LAST even with a low dose of a local anesthetic for patients with cardiac and renal failure. Keywords: transversus abdominis plane block, plasma concentration of ropivacaine, cardiac failure, renal dysfunction, central nervous toxicityhttps://www.dovepress.com/plasma-ropivacaine-concentration-after-tap-block-in-a-patient-with-car-peer-reviewed-article-LRATransversus abdominis plane blockplasma concentration of ropivacainecardiac and renal failurecentral nervous toxicity
spellingShingle Ishida T
Tanaka S
Sakamoto A
Hirabayashi T
Kawamata M
Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure
Local and Regional Anesthesia
Transversus abdominis plane block
plasma concentration of ropivacaine
cardiac and renal failure
central nervous toxicity
title Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure
title_full Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure
title_fullStr Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure
title_full_unstemmed Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure
title_short Plasma ropivacaine concentration after TAP block in a patient with cardiac and renal failure
title_sort plasma ropivacaine concentration after tap block in a patient with cardiac and renal failure
topic Transversus abdominis plane block
plasma concentration of ropivacaine
cardiac and renal failure
central nervous toxicity
url https://www.dovepress.com/plasma-ropivacaine-concentration-after-tap-block-in-a-patient-with-car-peer-reviewed-article-LRA
work_keys_str_mv AT ishidat plasmaropivacaineconcentrationaftertapblockinapatientwithcardiacandrenalfailure
AT tanakas plasmaropivacaineconcentrationaftertapblockinapatientwithcardiacandrenalfailure
AT sakamotoa plasmaropivacaineconcentrationaftertapblockinapatientwithcardiacandrenalfailure
AT hirabayashit plasmaropivacaineconcentrationaftertapblockinapatientwithcardiacandrenalfailure
AT kawamatam plasmaropivacaineconcentrationaftertapblockinapatientwithcardiacandrenalfailure